March 18, 2020, 09:00 AM EDT
Title: “Reducing Immunogenicity Risk With Pre-clinical Assays and Clinically Calibrated Modeling”
Speakers: Michael D. Knierman, B.S. and Richard E. Higgs, M.S.
LRL has invested recently in pre-clinical assays and technologies to better assess the risk of immunogenicity. This presentation will describe a key mass spectrometry proteomics assay and how it is being used alongside other assays with statistical modeling to provide teams an improved and clinically calibrated assessment of immunogenicity risk.